Rights Issue
Crescentis Capital Approves Rights Issue Documents
Crescentis Capital approved the Letter of Offer, Composite Application Form and Rights Entitlement letter for its ₹79.62 crore rights issue.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
2
Bullish
8
Bearish
36
Neutral
2
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Finance
Non Banking Financial Company (NBFC)
182 Cr
Low Risk
154.1
15.5
0.4
2.4
144.70
86.10
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Rights Issue
Crescentis Capital approved the Letter of Offer, Composite Application Form and Rights Entitlement letter for its ₹79.62 crore rights issue.
Board Meeting
Crescentis Capital will hold a board meeting on November 3, 2026, to approve rights issue documents, following BSE’s in-principle listing approval.
Board Meeting
Crescentis Capital will hold a Board meeting on November 3, 2026, to approve the Letter of Offer and related documents for its proposed rights issue of up to Rs 80 crore.
Rights Issue
Crescentis Capital has fixed November 4, 2026 as the record date to determine shareholders eligible for rights entitlements.
Rights Issue
Crescentis Capital approved a rights issue of 1,02,08,129 shares at Rs 78 per share, aggregating up to Rs 79.62 crore, with a 3:5 entitlement ratio.
Crescentis Capital Ltd (SOMDUTTFIN) is currently trading at 91.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Crescentis Capital Limited is an RBI-registered Non-Banking Financial Company primarily engaged in proprietary investments in listed equities and securities, and from June 2025 has begun regulated lending operations under the NBFC licence, marking a strategic move from a pure investment vehicle to a diversified financial services platform with both investment and lending income streams. The company completed a materially sized Rights Issue in June–July 2025 (70,05,579 equity shares at Rs.70), which was oversubscribed by more than 123%, resulting in proceeds reflected as equity issue inflows and a significant uplift in net worth and reserves, enabling a step-change in balance sheet scale from about Rs.3,022 lakhs to Rs.9,125 lakhs as at March 31, 2026. Financials show a transition year: the company reported interest income of Rs.325.21 lakhs and total income of Rs.154.60 lakhs for FY26, but delivered a consolidated PBT loss of Rs.320.37 lakhs and net loss of Rs.252.63 lakhs, driven by fair value mark-to-market swings, operating costs and early-stage loan deployment costs as the business pivots into lending. Balance sheet composition and cashflows are notable: loans of Rs.4,595.34 lakhs and investments of Rs.3,980.35 lakhs reflect rapid asset deployment, while cash flow from financing of Rs.6,325.40 lakhs financed operating cash outflows and investing activity; however, fair value losses of Rs.485.47 lakhs and pledged securities of Rs.3,062.51 lakhs create near-term liquidity and valuation considerations.
Over the past 52 weeks, Crescentis Capital Ltd has traded between a low of ₹86.10 and a high of ₹144.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Crescentis Capital Ltd has a market capitalization of approximately 181.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Crescentis Capital Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 154.13 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 181.87 Cr, Crescentis Capital Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Crescentis Capital Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Crescentis Capital Ltd is 154.13. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Crescentis Capital has fixed the issue price at ₹78 per equity share. This includes a face value of ₹10 and a premium of ₹68 per share.
Crescentis Capital has approved a rights issue of fully paid-up equity shares to raise up to ₹80 crore, including premium.
The company told BSE it moved the meeting by one day due to “unavoidable circumstances”, shifting it from September 29 to September 30, 2026.
For the quarter ended June 2026, sales were ₹10.94 crore and net profit was ₹7.82 crore, compared with ₹4.95 crore sales and ₹3.35 crore net profit a year earlier.